Advocates Back CA Medical MJ Regulation Initiative for 2012 Ballot

A comprehensive initiative to revamp California’s medical marijuana laws has been filed for the 2012 ballot: the Medical Marijuana Regulation, Control, and Taxation Act.

The initiative is designed to address widespread public concern over the confusing and chaotic state of medical marijuana laws in California. The lack of clear and unambiguous state laws regarding distribution and sales has been a major factor behind the continued federal raids on dispensaries and providers in California.

MMRCTA is designed so as to fulfill Prop 215’s mandate to establish “safe and affordable access” to all patients in medical need. The campaign is backed by a broad coalition of advocates including: ASA, the UFCW, Cal NORML, the Coalition for Cannabis Policy Reform, DPA, MPP, California Cannabis Association, the Emerald Growers’ Association, and others.

Sponsors believe that the MMRCTA is the most pressing and realistic ballot proposal for cannabis reform in California in 2012. Their campaign poll found that 70+% of California voters support uniform state rules for regulating, controlling and taxing medical marijuana, well above the 60% threshold that is regarded to be necessary for a successful initiative. In contrast, a slim 52% support full-scale adult legalization.

Sponsors have lined up start-up funding and are urgently seeking an additional $1 million in pledges for the petition drive, which is expected to launch around Feb. 9th. Donations can be made on-line to Californians to Regulate Medical Marijuana.

See initiative text and summary

– Dale Gieringer, MMRCTA campaign committee

Read more.

Californians to Regulate Medical Marijuana has launched a website

Californians to Regulate Medical Marijuana has launched a website (, expects broad-based support and is lining up financial commitments from patients, doctors, advocates and individuals for efforts to qualify the initiative for the November 2012 ballot.

Californians to Regulate Medical Marijuana

The California Medical Marijuana Regulation, Control and Taxation Act Will:

  • Establish a self-funded Bureau of Medical Marijuana Enforcement (BMME) under the Department of Consumer Affairs, which also regulates the California Medical Board and the Board of Pharmacy.
  • Outlaw the issuance or use of fraudulent physician recommendations.
  • Establish a 2.5% tax on the sale of medical marijuana to fund all BMME activities and pay for the registry system.
  • Allocate any surplus tax revenues funds — beyond those needed to run the BMME – to fund emergency medical services, low-income assistance and health services, scientific and educational grant programs, research into environmentally-sound cultivation practices.
  • Explicitly protect medical patients’ civil rights, which were implicit in voter-approved Prop. 215.
  • Mandate state registration after July 1, 2013 for every person in California engaged in cultivating, processing, manufacturing, transporting, distributing, selling medical marijuana for use by others.
  • Exempt patients and primary caregivers growing medical marijuana at home for personal use only.
  • Prohibit cities and counties from excluding the operation of state-permitted medical marijuana businesses, but explicitly permit the establishment of reasonable zoning regulations on the location of facilities.
  • Grant all California cities and counties the opportunity to ban medical marijuana dispensaries in their jurisdiction by voting affirmatively in a local ballot initiative election, provided they show that patients have adequate access to medical marijuana by other reasonable means.

Californians to Regulate Medical Marijuana Forms Campaign Committee

SACRAMENTO, Calif., Jan. 19, 2012 —  Committee Launches Campaign/Fundraising/Outreach Efforts to Qualify Initiative

SACRAMENTO, Calif., Jan. 19, 2012 /PRNewswire-USNewswire/ — Californians to Regulate Medical Marijuana (FPPC #1343895) has filed with the Secretary of State as a campaign committee to support the California Medical Marijuana Regulation, Control and Taxation Act.

71 percent of Californians support the state’s law allowing the use of marijuana for medical reasons. However, many Californians also want to see reforms to the current system to insure medical patients have continued access to marijuana but with clearer, stronger, and more uniform statewide rules. (See poll here)

The California Medical Marijuana Regulation, Control and Taxation Act, filed by Americans for Safe Access and UFCW Local 5 with the CA Attorney General, calls for uniform statewide policy and oversight; uniform statewide taxation; and stronger penalties for fraudulent medical recommendations.

Read more…

The Seventh National Clinical Conference on Cannabis Therapeutics

The Seventh National Clinical Conference on Cannabis Therapeutics will be held April 26-28, 2012 at Loews Ventana Canyon Resort in Tucson, Arizona!

A Compassionate, Science-based Educational Forum for the Restoration of Medical Cannabis Knowledge

Since the marijuana prohibition began in 1937 and cannabis was subsequently removed from the pharmacopoedia by 1941, cannabis as a medicine was no longer included in medical education. Beginning in 2000, Patients Out of Time began its biennial series of national clinical conferences on cannabis therapeutics. The goal was to re-introduce cannabis as medicine to healthcare professionals with current evidence based research in an accredited forum. In order for research to be considered of merit it must be replicated and peer reviewed. The results must then be made public, scrutinized, and validated. Patients Out of Time brings together cannabis/cannabinoid researchers from around the world as well as clinicians, patients, and others to provide this needed education. Conference Agenda..

Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol(CBD) on experimental colon cancer.


Aviello G, Romano B, Borrelli F, Capasso R, Gallo L, Piscitelli F, Di Marzo V, Izzo AA.

Department of Experimental Pharmacology, Endocannabinoid Research Group, University of Naples Federico II, Naples, Italy.


Colon cancer affects millions of individuals in Western countries. Cannabidiol, a safe and non-psychotropic ingredient of Cannabis sativa, exerts pharmacological actions (antioxidant and intestinal antinflammatory) and mechanisms (inhibition of endocannabinoid enzymatic degradation) potentially beneficial for colon carcinogenesis. Thus, we investigated its possible chemopreventive effect in the model of colon cancer induced by azoxymethane (AOM) in mice. AOM treatment was associated with aberrant crypt foci (ACF, preneoplastic lesions), polyps, and tumour formation, up-regulation of phospho-Akt, iNOS and COX-2 and down-regulation of caspase-3. Cannabidiol-reduced ACF, polyps and tumours and counteracted AOM-induced phospho-Akt and caspase-3 changes. In colorectal carcinoma cell lines, cannabidiol protected DNA from oxidative damage, increased endocannabinoid levels and reduced cell proliferation in a CB(1)-, TRPV1- and PPARγ-antagonists sensitive manner. It is concluded that cannabidiol exerts chemopreventive effect in vivo and reduces cell proliferation through multiple mechanisms.